David S. Carter

1.3k total citations
42 papers, 877 citations indexed

About

David S. Carter is a scholar working on Organic Chemistry, Molecular Biology and Education. According to data from OpenAlex, David S. Carter has authored 42 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Education. Recurrent topics in David S. Carter's work include Pharmacological Receptor Mechanisms and Effects (4 papers), Cyclopropane Reaction Mechanisms (4 papers) and Catalytic C–H Functionalization Methods (3 papers). David S. Carter is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (4 papers), Cyclopropane Reaction Mechanisms (4 papers) and Catalytic C–H Functionalization Methods (3 papers). David S. Carter collaborates with scholars based in United States, United Kingdom and Ireland. David S. Carter's co-authors include David L. Van Vranken, Kevin L. Greenman, Joseph Janes, Andrew Vogt, Yansheng Zhai, Michael P. Dillon, Anthony Ford, Joel R. Gever, Lee A. Flippin and Alam Jahangir and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Antimicrobial Agents and Chemotherapy and The Journal of Organic Chemistry.

In The Last Decade

David S. Carter

38 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David S. Carter United States 17 387 143 110 106 81 42 877
Ralph Gabbard United States 15 170 0.4× 284 2.0× 91 0.8× 4 0.0× 19 0.2× 33 1.2k
Tingting Liu China 19 76 0.2× 288 2.0× 25 0.2× 5 0.0× 15 0.2× 106 1.1k
Jacqueline E. van Muijlwijk‐Koezen Netherlands 17 323 0.8× 524 3.7× 21 0.2× 255 2.4× 37 892
Michelle Martínez United States 24 40 0.1× 521 3.6× 91 0.8× 9 0.1× 32 0.4× 61 1.4k
James H. Jones United States 18 158 0.4× 321 2.2× 222 2.0× 9 0.1× 50 1.2k
P. K. Rangachari Canada 19 29 0.1× 267 1.9× 22 0.2× 5 0.0× 8 0.1× 78 1.0k
Priti Jain India 12 38 0.1× 167 1.2× 64 0.6× 2 0.0× 19 0.2× 43 501
Mark Carroll United Kingdom 19 203 0.5× 625 4.4× 10 0.1× 29 0.3× 65 1.2k
Gottfried Zimmermann Germany 20 283 0.7× 171 1.2× 51 0.5× 4 0.0× 86 1.2k
Walter Schilling United States 14 206 0.5× 356 2.5× 12 0.1× 4 0.0× 68 793

Countries citing papers authored by David S. Carter

Since Specialization
Citations

This map shows the geographic impact of David S. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Carter more than expected).

Fields of papers citing papers by David S. Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Carter. The network helps show where David S. Carter may publish in the future.

Co-authorship network of co-authors of David S. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Carter. A scholar is included among the top collaborators of David S. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Carter. David S. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Padilla, Ángel M., Wei Wang, Tsutomu Akama, et al.. (2022). Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates. Nature Microbiology. 7(10). 1536–1546. 39 indexed citations
2.
Carter, David S., et al.. (2019). An investigation of the inter-molecular interaction, solid-state properties and dissolution properties of mixed copovidone hot-melt extruded solid dispersions. Journal of Drug Delivery Science and Technology. 53. 101132–101132. 18 indexed citations
3.
Korkegian, Aaron, Theresa O’Malley, Yi Xia, et al.. (2017). The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis. Tuberculosis. 108. 96–98. 24 indexed citations
4.
Lucas, Matthew C., Robert J. Weikert, David S. Carter, et al.. (2010). Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain. Bioorganic & Medicinal Chemistry Letters. 20(18). 5559–5566. 15 indexed citations
5.
Carter, David S., Haiying Cai, Eun Kyung Lee, et al.. (2010). 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression. Bioorganic & Medicinal Chemistry Letters. 20(13). 3941–3945. 25 indexed citations
6.
Carter, David S., Haiying Cai, Michael P. Dillon, et al.. (2009). Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X3/P2X2/3 antagonist for the treatment of pain. Bioorganic & Medicinal Chemistry Letters. 19(6). 1628–1631. 54 indexed citations
7.
Lucas, Matthew C., David S. Carter, Haiying Cai, et al.. (2009). Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(16). 4630–4633. 4 indexed citations
8.
Dillon, Michael P., Anthony Ford, Joel R. Gever, et al.. (2009). Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 20(3). 1031–1036. 36 indexed citations
9.
Jahangir, Alam, David S. Carter, Michael P. Dillon, et al.. (2009). Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X3/P2X2/3 antagonist for the treatment of pain. Bioorganic & Medicinal Chemistry Letters. 19(6). 1632–1635. 42 indexed citations
10.
Carter, David S., et al.. (2005). Website redesign and testing with a usability consultant: lessons learned. OCLC Systems & Services. 21(3). 156–166. 12 indexed citations
11.
Carter, David S.. (2005). Distributed practicum supervision in a managed learning environment (MLE). Teachers and Teaching. 11(5). 481–497. 10 indexed citations
12.
Carter, David S.. (2002). Elements of Digital Libraries, Present and Future. 3–7. 4 indexed citations
13.
Carter, David S.. (2002). Hurry Up and Wait. The Reference Librarian. 38(79-80). 113–120. 23 indexed citations
14.
Carter, David S. & Joseph Janes. (2000). Unobtrusive Data Analysis of Digital Reference Questions and Service at the Internet Public Library: An Exploratory Study.. Library trends. 49(2). 251–265. 68 indexed citations
15.
Carter, David S. & David L. Van Vranken. (2000). Iron-Catalyzed Doyle−Kirmse Reaction of Allyl Sulfides with (Trimethylsilyl)diazomethane. Organic Letters. 2(9). 1303–1305. 41 indexed citations
16.
Janes, Joseph, et al.. (1999). Digital Reference Services in Academic Libraries. Reference & User Services Quarterly. 39(2). 145–150. 60 indexed citations
17.
Carter, David S., et al.. (1994). Concise Synthesis of Narcissus Pyrrolophenanthridine Alkaloids: Vasconine, Assoanine and Oxoassoanine. The Journal of Organic Chemistry. 59(12). 3497–3499. 25 indexed citations
18.
Carter, David S., et al.. (1993). Nucleophilic aromatic substitution on aromatic aldimines. Tetrahedron Letters. 34(20). 3255–3258. 10 indexed citations
19.
Carter, David S. & Andrew Vogt. (1980). Collinearity-preserving functions between Desarguesian planes. Proceedings of the National Academy of Sciences. 77(7). 3756–3757. 20 indexed citations
20.
Allred, J. C. & David S. Carter. (1958). Kinetics of Homogeneous Power Reactors of the LAPRE Type. Nuclear Science and Engineering. 3(5). 482–503. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026